Drug Search Results
More Filters [+]

BIA-101

Alternative Names: bia-101, bia101, bia 101
Latest Update: 2024-03-05
Latest Update Note: PubMed Publication

Product Description

to measure impedance during inpatient treatment (Sourced from: https://clinicaltrials.gov/ct2/history/NCT01509495?V_3=View)

Mechanisms of Action: Unknown

Novel Mechanism: No

Modality: N/A

Route of Administration: N/A

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Medtronic
Company Location: DUBLIN L2 2
Company CEO: Geoffrey S. Martha
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for BIA-101

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 1: Heart Failure

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

SIM-HF

P1

Terminated

Heart Failure

2014-05-01

Recent News Events